Fetal growth restriction: Doppler surveillance and delivery timing

Fetal growth restriction (FGR) is a placental insufficiency syndrome in which a fetus fails to reach its biological growth potential. It is often identified through a small estimated fetal weight (EFW) or abdominal circumference, yet size alone cannot show whether the fetus is constitutionally small, adapting safely, or becoming progressively hypoxic. That distinction makes surveillance central to care.

Ultrasound biometry, amniotic fluid assessment, fetal movement, cardiotocography, and Doppler velocimetry each provide a different view of fetal wellbeing. Used together, they help clinicians recognize deteriorating placental function and balance the hazards of continuing pregnancy against those associated with preterm birth.

The scientific discussions associated with FAOPS 2020 resources reflected the importance of coordinated perinatal care, research-based decision-making, and communication between maternal-fetal medicine, neonatology, and obstetric teams. Although the Tokyo congress was canceled in 2020 because of the COVID-19 pandemic, its clinical themes remain relevant to modern fetal surveillance.

Why growth restriction requires close surveillance

FGR may result from placental dysfunction, hypertensive disease, maternal illness, infection, fetal anomaly, chromosomal conditions, or multiple gestation. Early-onset disease, usually recognized before 32 weeks, is more likely to involve severe placental pathology and abnormal fetal hemodynamics. Late-onset FGR can be subtler: the EFW may remain above the tenth percentile while cerebral blood flow and fetal growth patterns signal reduced placental reserve.

A single scan cannot describe the full trajectory. Growth should be assessed with measurements taken at an appropriate interval, since very short gaps can make normal measurement variation appear clinically meaningful. Serial assessment of EFW, abdominal circumference, fluid volume, and Doppler findings gives a clearer picture of whether the fetus is stable, compensating, or deteriorating.

Clinicians also need to distinguish FGR from a constitutionally small fetus. A small fetus with normal interval growth, normal umbilical artery flow, reassuring fluid, and no maternal disease may have a different risk profile from a fetus with declining growth velocity and increasing placental resistance. Customized assessment, parental characteristics, gestational age, and the complete clinical context can prevent an isolated percentile from driving an unsafe decision.

How Doppler findings reveal fetal adaptation

The umbilical artery (UA) Doppler is the principal tool for assessing placental resistance in suspected FGR. As placental vascular resistance rises, end-diastolic flow may become elevated, absent, or reversed. These patterns indicate progressively impaired placental exchange and are associated with increasing perinatal risk, particularly in early-onset disease.

The middle cerebral artery (MCA) Doppler provides information about fetal redistribution. A reduced MCA pulsatility index can indicate cerebral vasodilation, sometimes called the brain-sparing response. This adaptation may preserve blood flow to vital organs, but it does not guarantee fetal safety. In late-onset FGR, an abnormal MCA or cerebroplacental ratio (CPR) can be clinically important even when the UA Doppler appears normal.

The ductus venosus (DV) Doppler is most useful in severe, early FGR when cardiac strain and acid-base deterioration are concerns. Abnormal atrial flow can suggest advanced compromise, although interpretation should be performed by experienced clinicians and integrated with cardiotocography, biophysical assessment, gestational age, and maternal status. Uterine artery Doppler may support risk assessment by indicating impaired maternal placentation, but it is not a substitute for ongoing fetal surveillance after FGR has been diagnosed.

Doppler values should be interpreted according to validated gestational-age reference ranges and the equipment’s technical limitations. The waveform quality, sampling technique, fetal breathing, maternal heart rate, and operator experience can influence results. Trends are often more informative than a single borderline measurement.

Matching surveillance intensity to clinical risk

Delivery timing is a risk-balancing exercise rather than a response to one number. Continuing pregnancy may allow additional maturation, especially in a very preterm fetus, while prolonged exposure to placental insufficiency can lead to stillbirth, acidosis, emergency delivery, or neurological injury. The safest plan changes as gestational age, Doppler severity, growth trajectory, and maternal disease evolve.

The following framework summarizes common clinical interpretations. Local protocols and specialist judgment remain essential because thresholds and recommended intervals vary among professional organizations.

Antenatal corticosteroids should be considered when preterm birth is likely within the clinically appropriate window, and magnesium sulfate may be indicated for fetal neuroprotection at very early gestations according to local guidance. These interventions support preparation for birth; they do not remove the need to act when fetal compromise is advancing.

The maternal and fetal context changes the plan

Maternal hypertension, preeclampsia, renal disease, diabetes with vascular complications, autoimmune disease, smoking, and thrombophilia may increase the likelihood of placental insufficiency. New symptoms such as headache, visual disturbance, right upper-quadrant pain, vaginal bleeding, reduced fetal movement, or severe blood pressure elevation can require urgent reassessment, regardless of the previous Doppler result.

The fetus also needs evaluation beyond growth and blood flow. Structural anomalies, aneuploidy risk, congenital infection, and genetic conditions are more relevant in some early or severe presentations. Amniotic fluid abnormalities, non-reassuring cardiotocography, poor biophysical profile, and a marked fall in growth velocity may all influence delivery timing.

Perinatal infection and maternal deterioration add another layer of urgency. Teams reviewing complex cases can draw on broader educational material such as peripartum sepsis guidance, particularly when fever, abnormal vital signs, uterine tenderness, or fetal tachycardia complicate the assessment. Infection is not a typical cause of every FGR case, but missed maternal sepsis can rapidly change the safest location and timing of birth.

Shared decision-making should include the parents, maternal-fetal medicine specialist, neonatologist, and the clinicians responsible for delivery. Counseling is clearer when it explains what each test shows, what uncertainty remains, which findings would trigger delivery, and what neonatal support may be required at the expected gestational age.

Creating a dependable surveillance pathway

A practical pathway begins with confirmation of gestational age and a careful review of prior measurements. The clinician should document EFW and abdominal circumference percentiles, growth velocity, fluid volume, UA and relevant additional Dopplers, maternal blood pressure, symptoms, and fetal movement. The record should make the direction of change easy to identify.

Surveillance frequency should reflect risk. Stable, mild FGR with normal Doppler findings may be monitored as an outpatient, while abnormal UA flow, early gestational age, severe growth restriction, or maternal disease may require much closer review or hospital admission. A plan should specify who reviews results, how quickly abnormal findings are communicated, and where delivery will occur if urgent neonatal support is needed.

Useful elements of a coordinated plan include:

• Confirm gestational age, fetal number, chorionicity, and the reliability of previous ultrasound measurements.
• Repeat growth assessment at clinically meaningful intervals while using Doppler and fetal testing between growth scans.
• Interpret UA, MCA, CPR, and DV findings together rather than treating one waveform as an isolated verdict.
• Establish explicit escalation criteria for admission, corticosteroids, neuroprotection, multidisciplinary review, and delivery.
• Prepare the neonatal team early when prematurity, severe FGR, abnormal testing, or anticipated respiratory and feeding problems are likely.

The mode of birth also deserves individualized planning. FGR with reassuring testing does not automatically require cesarean birth, and induction may be appropriate at a gestation when vaginal delivery is considered safe. Severe Doppler abnormalities, persistent non-reassuring fetal status, malpresentation, or an inability to tolerate labor may favor cesarean delivery. Continuous intrapartum monitoring is generally important because a growth-restricted fetus may have limited reserve during contractions.

From evidence to timely action

The most reliable approach to FGR combines serial information with readiness to change course. A normal result today does not eliminate risk tomorrow, while an abnormal result should be interpreted in relation to gestational age, severity, reproducibility, and the condition of the mother and fetus. Clear documentation and direct communication reduce delays when the clinical picture shifts.

Clinicians can use this framework to review local protocols, audit intervals between abnormal findings and delivery, and strengthen referral pathways to tertiary maternal-fetal and neonatal services. Families should receive understandable explanations of surveillance results and warning signs, including reduced fetal movement and symptoms of hypertensive disease.

Timely specialist assessment, consistent Doppler technique, and a documented delivery plan help turn fetal monitoring into effective perinatal care. Apply those principles in multidisciplinary practice so that each decision reflects both the risks of prematurity and the danger of continuing a compromised pregnancy.